Reported 5 days ago
Hims & Hers saw its stock price jump over 24% following a controversial Super Bowl advertisement that criticized the U.S. healthcare system while promoting affordable GLP-1 weight-loss drugs. The ad sparked debate, prompting concerns from lawmakers about safety information being omitted. With the stock now up 100% for the year, retail investor interest and recent Senate developments regarding health policy have contributed to its rise, even as debates about drug supply and safety continue.
Source: YAHOO